+Search query
-Structure paper
| Title | Molecular mechanism of allosteric modulation of opioid receptors. |
|---|---|
| Journal, issue, pages | Signal Transduct Target Ther, Vol. 11, Year 2026 |
| Publish date | Oct 29, 2025 |
Authors | Heli Wang / Zhuang Miao / Chang Zhao / Hong Fu / Xiaowen Tian / Xinlei Liu / Lei Wang / Yuan Liu / Xingyu Liu / Xihao Yong / Lantian Su / Wei Yan / Lin Cheng / Renjie Chai / Zhenhua Shao / Bowen Ke / ![]() |
| PubMed Abstract | Opioid analgesics provide potent pain relief but are limited by severe adverse effects, tolerance, and interindividual genetic variability in response. Poly-pharmacology and allosteric modulation of ...Opioid analgesics provide potent pain relief but are limited by severe adverse effects, tolerance, and interindividual genetic variability in response. Poly-pharmacology and allosteric modulation of opioid receptors offer promising strategies to enhance analgesic efficacy while mitigating these limitations. Pan-positive allosteric modulators (pan-PAMs), which simultaneously potentiate multiple opioid receptor subtypes, integrate the advantages of both approaches and represent an emerging therapeutic paradigm for pain management. However, the molecular mechanisms underlying pan-PAM activity at opioid receptors remain poorly understood. Here, we characterize BMS-986187 as a pan-PAM of opioid receptors and report the cryo-electron microscopy (cryo-EM) structures of multiple opioid receptor subtypes bound to this modulator, revealing a previously unidentified allosteric pocket. Structural and functional analyses revealed a conserved binding motif that mediates PAM recognition across the opioid receptor family and revealed the essential contributions of key opioid receptor residues to allosteric modulation by BMS-986187. Functionally, BMS-986187 enhances analgesic efficacy through an opioid-sparing effect, allowing lower opioid doses and reducing side effects, while restoring activity in loss-of-function (LOF) μ-opioid receptor variants. These findings define a previously unrecognized allosteric site in opioid receptors and establish a structural framework for the rational design of safer and more effective opioid therapeutics through allosteric modulation. |
External links | Signal Transduct Target Ther / PubMed:42362532 / PubMed Central |
| Methods | EM (single particle) |
| Resolution | 2.52 - 3.22 Å |
| Structure data | EMDB-66723, PDB-9xc6: ![]()
EMDB-66725: BMS-986187-bound MOR-Gi1 G Protein EM map ![]()
EMDB-66726: The overall map of BMS-986187-bound MOR-Gi1 complex ![]()
EMDB-66730: The receptor local map of BMS-986187-bound MOR-Gi1 complex EMDB-66771, PDB-9xdq: EMDB-66773, PDB-9xdr: EMDB-66801, PDB-9xf4: ![]()
EMDB-66825: The receptor local map of BMS-986187-bound DOR-Gi2 complex ![]()
EMDB-66826: The G PROTEIN map of BMS-986187-bound DOR-Gi1 complex ![]()
EMDB-66827: The overall map of BMS-986187-bound DOR-Gi2 complex ![]()
EMDB-66828: The receptor local map of asimadoline-BMS-986187-bound KOR-Gi1 complex ![]()
EMDB-66829: The G PROTEIN map of asimadoline-BMS-986187-bound KOR-Gi1 complex ![]()
EMDB-66830: The overall map of asimadoline-BMS-986187-bound KOR-Gi1 complex ![]()
EMDB-66831: The receptor local map of Leu-enkephalin-BMS-986187-bound DOR-Gi complex ![]()
EMDB-66832: The Gi protein local map of Leu-enkephalin-BMS-986187-bound DOR-Gi complex ![]()
EMDB-66833: The overall map of Leu-enkephalin-BMS-986187-bound DOR-Gi complex |
| Chemicals | ![]() PDB-1d6b: ![]() PDB-1esg: ![]() PDB-1e0f: |
| Source |
|
Keywords | MEMBRANE PROTEIN / Complex / Agonist / PAM |
Movie
Controller
Structure viewers
About Yorodumi Papers



Authors
External links







homo sapiens (human)
oplophorus gracilirostris (arthropod)
Keywords